Diabetes: Insulet seeks FDA nod for next-generation OmniPod insulin pump

May 10, 2011 by MassDevice staff

Insulet Corp. says it is seeking 510(k) clearance from the FDA for a smaller, lighter Omnipod insulin management system and reports a 36 percent first-quarter sales jump.

PODD logo

Insulet Corp. (NSDQ:PODD) is hoping to win 510(k) clearance* for a new Omnipod officials said will help the company reduce its production costs by more than a third.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp